The Principles
Induction, competence, and positional information
Development requires cells to know three things: what they are, where they are, and when to act. Three principles organize how signaling achieves this:
Induction: one group of cells (the inducer) signals to an adjacent group (the responder) to change its developmental fate. The organizer (Spemann organizer in amphibians, the node in mammals) is the most famous inducing tissue — it secretes signals that induce neural tissue and establish the body axes.
Competence: the ability of a cell to respond to an inductive signal. Competence depends on which receptors and downstream signaling components the cell expresses. The same signal produces different responses in different cell types because different cells have different competence states.
Positional information: cells determine their position within the embryo by reading the concentration of morphogens — signaling molecules that form gradients across the embryo. High concentrations specify one fate; low concentrations specify another. The French flag model (Wolpert) illustrates how a single morphogen gradient can specify three distinct regions by having two threshold concentrations.
💡 Retinoic Acid — A Morphogen with Therapeutic Consequences
Retinoic acid (RA), the active form of vitamin A, is one of the best-studied morphogens. It forms a posterior-high/anterior-low gradient along the anteroposterior axis of the embryo and controls Hox gene expression — specifying regional identity from head to tail.
High RA → posterior Hox genes expressed → posterior identity. Low RA → anterior Hox genes → anterior (head) identity.
Therapeutic use: All-trans retinoic acid (ATRA) induces differentiation of acute promyelocytic leukemia (APL) cells — the PML-RARα fusion protein blocks RA receptor function, and pharmacologic doses of ATRA overcome this block, causing APL cells to differentiate and stop proliferating. ATRA + arsenic trioxide cures >90% of APL, making it one of the most successfully treated leukemias.
Teratogenicity: Excess RA (from isotretinoin or vitamin A supplements) is severely teratogenic — disrupts Hox gene expression, neural crest migration, and craniofacial development. This is why isotretinoin requires strict contraception requirements.
Wnt
Wnt signaling — body axis, cell fate, and cancer
Wnt ligands bind Frizzled receptors → inhibit GSK-3β → β-catenin accumulates (not phosphorylated/degraded) → β-catenin enters nucleus → activates Wnt target genes (cyclin D1, c-Myc, AXIN2).
Developmental roles: establishes the dorsoventral axis in vertebrates (Wnt signals from the organizer inhibit BMP on the dorsal side). Patterns the anteroposterior axis of the gut. Specifies cell fate in the intestinal crypt (stem cell niche). Controls left-right axis specification.
Cancer: APC gene (adenomatous polyposis coli) is normally a negative regulator of Wnt signaling — it is part of the destruction complex that phosphorylates β-catenin for degradation. APC mutation → constitutive β-catenin nuclear activity → uncontrolled proliferation → colorectal cancer. APC is mutated in >80% of colorectal cancers. Familial adenomatous polyposis (FAP) = inherited APC mutation → thousands of colonic polyps → near-certain colorectal cancer by age 40.
Memory trick: Wnt ON = β-catenin survives and goes to nucleus. Wnt OFF = GSK-3β destroys β-catenin. APC = part of the destruction complex = tumor suppressor. APC mutation = Wnt always ON = colorectal cancer.
Hedg
Hedgehog signaling — limb patterning and basal cell carcinoma
Hedgehog (Hh) ligands (Sonic Hedgehog = SHH in vertebrates) bind and inactivate the Patched (PTCH1) receptor → Smoothened (SMO) is derepressed → Gli transcription factors activated → Hh target genes expressed.
Developmental roles: SHH from the zone of polarizing activity (ZPA) at the posterior limb bud creates an anteroposterior gradient that specifies digit identity (which finger is which). SHH from the notochord and floorplate patterns the ventral neural tube (specifying motor neuron identity). SHH patterns the ventral midline of the brain.
Cancer: Loss-of-function PTCH1 mutations → SMO constitutively active → basal cell carcinoma (the most common cancer in humans). Also causes Gorlin syndrome (nevoid BCC syndrome). Vismodegib is an SMO inhibitor approved for advanced BCC — directly targeting dysregulated Hedgehog signaling.
Memory trick: SHH = Sonic Hedgehog. Specifies digit identity from posterior limb bud (pinky side). PTCH1 = tumor suppressor. PTCH1 mutation = SMO on = BCC.
Notch
Notch signaling — lateral inhibition and binary cell fate
Notch signaling requires direct cell-cell contact: Notch receptor on one cell binds Delta/Jagged ligand on the adjacent cell → proteolytic cleavage releases the Notch intracellular domain (NICD) → NICD enters nucleus → activates Hes/Hey target genes (transcriptional repressors).
Lateral inhibition: a cell that activates Notch in its neighbor suppresses that neighbor from adopting the same fate, creating a salt-and-pepper pattern of two alternating cell types. This is how neural progenitor cells (all equal) give rise to a mix of neurons and glial cells — a neuron activates Notch in its neighbors, suppressing them from also becoming neurons.
Cancer: NOTCH1 mutations (gain-of-function) → constitutive Notch signaling → T-cell acute lymphoblastic leukemia (T-ALL). Also implicated in breast cancer and colorectal cancer.
Memory trick: Notch = the cell-cell contact pathway. Lateral inhibition = 'I become a neuron so my neighbor cannot.' NOTCH1 mutation = T-ALL.
BMP
BMP signaling — dorsoventral patterning and bone formation
Bone morphogenetic proteins (BMPs) are TGF-β family members that signal through SMAD transcription factors. BMP binding to Type I + Type II receptor complex → SMAD1/5/8 phosphorylated → SMAD4 complex enters nucleus → activates BMP target genes.
Developmental roles: BMP4 from the ventral side of the embryo specifies ventral mesoderm (blood, lateral plate). The Spemann organizer (dorsal side) secretes BMP antagonists (Noggin, Chordin, Follistatin) → BMP activity is low on the dorsal side → dorsal mesoderm becomes somites and notochord. This BMP gradient establishes the dorsoventral axis. BMPs also induce apoptosis between the digits (removing the webbing).
BMP signaling in adult tissue: promotes bone formation (BMPs were originally discovered as factors that could induce ectopic bone formation). BMP2 and BMP7 are used clinically to promote spinal fusion and fracture healing.
Memory trick: BMP = ventralizing signal. Organizer blocks BMP on dorsal side. BMP high = ventral (blood, lateral plate). BMP low (blocked by Noggin/Chordin) = dorsal (neural, somites).
🔬 Clinical Scenario — Developmental Pathways as Cancer Targets
The same pathways that build embryos drive cancer when dysregulated in adults:
A
Wnt/APC → colorectal cancer. The adenoma-carcinoma sequence in the colon begins with APC mutation (Wnt pathway constitutively ON) → adenomatous polyp → then sequential mutations in KRAS, SMAD4, and TP53 accumulate → invasive carcinoma. FAP patients inherit one APC mutation and develop thousands of polyps — the Knudson two-hit principle applied to a Wnt pathway tumor suppressor.
B
SHH/PTCH1 → basal cell carcinoma and medulloblastoma. BCC is the most common human cancer — almost all are caused by PTCH1 mutations (sporadic) or Gorlin syndrome (inherited). Vismodegib (SMO inhibitor) and sonidegib are approved for locally advanced and metastatic BCC. Medulloblastoma (cerebellar tumor, most common malignant brain tumor of childhood) frequently has Hedgehog pathway activation — SHH-subgroup medulloblastoma responds to SMO inhibitors.
C
Notch → T-ALL. NOTCH1 gain-of-function mutations are present in >50% of T-cell acute lymphoblastic leukemias. NOTCH1 normally promotes T-cell development — constitutive activation locks cells in a proliferative progenitor state. Gamma-secretase inhibitors (which prevent NOTCH cleavage and NICD release) are in clinical trials for T-ALL.
D
FGF signaling → craniosynostosis. Fibroblast growth factor receptors (FGFRs) regulate skull suture fusion. FGFR2 gain-of-function mutations cause premature fusion of skull sutures (craniosynostosis) in Apert syndrome (FGFR2 Ser252Trp or Pro253Arg) and Crouzon syndrome (multiple FGFR2 mutations) → abnormal head shape, midface hypoplasia, and (in Apert) fused digits (syndactyly). FGFR3 gain-of-function mutations cause achondroplasia (most common form of dwarfism) by inhibiting chondrocyte proliferation.
⚠️ The Most Commonly Confused Signaling Concepts
Wnt ON means β-catenin is STABLE (NOT degraded). When Wnt is OFF, GSK-3β phosphorylates β-catenin → ubiquitinated → proteasomal degradation. When Wnt is ON, the destruction complex (APC/AXIN/GSK-3β) is inhibited → β-catenin accumulates and enters the nucleus. Students get this backwards — Wnt on = β-catenin lives. Wnt off = β-catenin dies.
PTCH1 normally INHIBITS SMO. Hedgehog signaling works by relieving inhibition. Without Hedgehog ligand: PTCH1 inhibits SMO → pathway off. With Hedgehog: PTCH1 is inhibited → SMO is free to activate Gli. PTCH1 loss-of-function ACTIVATES the pathway (by releasing SMO from inhibition). This double-negative logic confuses students.
BMP = ventralizing, NOT dorsalizing. BMP4 specifies ventral identity. The dorsal organizer blocks BMP to establish dorsal identity. Students intuitively think 'bone morphogenetic protein' sounds structural/dorsal — but BMP signals specify the ventral side (blood, lateral plate mesoderm). The dorsal side is defined by the ABSENCE of BMP signaling.
✓ Quick Self-Test
1. What is the role of β-catenin in Wnt signaling, and what happens when APC is mutated?
2. How does SHH specify digit identity in the developing limb bud?
3. What is lateral inhibition in Notch signaling? Give a developmental example.
4. What establishes the dorsoventral axis in vertebrate embryos in terms of BMP signaling?
5. How is retinoic acid used therapeutically in cancer treatment?
Answers:
1. In Wnt-ON state, the destruction complex (including APC) is inhibited → β-catenin is not phosphorylated → β-catenin accumulates and enters the nucleus → activates proliferative target genes. APC mutation inactivates the destruction complex → β-catenin is constitutively active → uncontrolled proliferation → colorectal cancer.
2. SHH secreted from the zone of polarizing activity (ZPA) at the posterior limb bud creates a posterior-high/anterior-low concentration gradient. High SHH → posterior digit identity (pinky/digit 5). Low SHH → anterior identity (thumb/digit 1). The concentration of SHH specifies which finger is which.
3. In lateral inhibition, a cell that activates Notch in its neighbor suppresses that neighbor from adopting the same fate — creating alternating cell types. Example: a neural progenitor that commits to becoming a neuron upregulates Delta, activating Notch in neighboring progenitors → Notch activation in neighbors suppresses their neuronal differentiation → neighbors become glia instead.
4. BMP4 from ventral tissue specifies ventral mesoderm (lateral plate, blood). The Spemann organizer/node (dorsal side) secretes BMP antagonists (Noggin, Chordin) → BMP activity is low dorsally → dorsal mesoderm becomes somites and notochord. The BMP gradient (high ventral, low dorsal) is the primary signal establishing the dorsoventral axis.
5. All-trans retinoic acid (ATRA) is used to treat acute promyelocytic leukemia (APL). The PML-RARα fusion protein in APL cells blocks retinoic acid receptor function at normal RA concentrations. Pharmacologic doses of ATRA overcome this block → APL cells differentiate → stop proliferating. ATRA + arsenic trioxide cures >90% of APL.